MICHAEL UNGER: Open Payments
NPI 1316995608 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 11 payments from 9 companies in 2025. Trend: 2023 $249 · 2024 $336 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Almatica Pharma LLC | 1 | $31 |
| Boston Scientific Corporation | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Qelbree, Auvelity, LOREEV XR, General - Pain Management, Dyanavel XR, VRAYLAR, INVEGA SUSTENNA, Xelstrym.
Industry payments across GA — which companies pay providers there.
